The order in which genetic mutations are acquired determines how an individual cancer behaves, according to research from the University of Cambridge, published today in the New England Journal of Medicine.
The first comprehensive computer model to simulate the development of blood cells could help in the development of new treatments for leukaemia and lymphoma, say researchers at the University of Cambridge and Microsoft Research.
Human stem cell research holds promise for combating some of the most recalcitrant of diseases and for regenerating damaged bodies. It is also an ethical, legal and political minefield.
DefiniGEN is one of the first commercial opportunities to arise from Cambridge’s expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic cells for drug screening.
Looking at stem cells through physicists’ eyes is challenging some of our basic assumptions about the body’s master cells.
Stem cells – the body’s master cells – demonstrate a bizarre property never before seen at a cellular level, according to a study published today from scientists at the University of Cambridge.
Cambridge research that has for the first time successfully grown “mini-livers” from adult mouse stem cells has won the UK’s international prize for the scientific and technological advance with the most potential to replace, reduce or refine the use of animals in science (the 3Rs).
A new technique for determining what causes stem cells to convert into other cell types could revolutionise our understanding of how genes function.
A new test for blood cancers will catch many more cases than the present test that identifies only 60 per cent.
Study has relevance to all cancers that are suspected to have a stem cell origin
© 2025 University of Cambridge